Back

Defining the Limits of hPSC Derived Models: hPSC-MSNs Fail to Recapitulate Authentic Striatal Identity

Bartley, O. J. M.; Vinh, N.-N.; Lelos, M.; Williams, N. M.; Precious, S. V.; Rosser, A. E.

2025-07-16 cell biology
10.1101/2024.06.25.600518 bioRxiv
Show abstract

Human pluripotent stem cells (hPSCs) are increasingly used to model human disease and as donor cells for regenerative medicine. However, the fidelity of hPSC-derived cell types remains a major concern, particularly when these cells are intended to replicate complex or region-specific subtypes, such as those required to explore and treat neurological diseases. Medium spiny neurons (MSNs), the principal projection neurons of the striatum, are one such target cell type relevant to disorders such as Huntingtons disease. While protocols for generating hPSC-derived MSNs (hPSC-MSNs) exist, the extent to which these cells faithfully recapitulate their genuine counterparts is unclear. Here, we generated isogenic human induced pluripotent stem cells (hiPSCs) from striatal (LGE) and non-neural (fibroblast) fetal tissues, and differentiated them into MSN-like cells alongside a naive human embryonic stem cell (hESC) line. Using DNA methylation profiling and single-cell RNA sequencing, we systematically compared the epigenetic and transcriptional features of these hPSC-MSNs to authentic fetal MSNs. Our findings reveal persistent epigenetic signatures inherited from the tissue of origin, which influence differentiation outcomes. While LGE-derived hiPSCs retained elements of a striatal-biased methylome and yielded MSN-like cells with enhanced similarity to authentic MSNs, all hPSC-MSNs remained epigenetically and transcriptionally distinct from genuine MSNs and we identified clusters of hPSC-derived cells with aberrant or incomplete phenotypes. These results demonstrate that even isogenic hiPSC lines exhibit variable differentiation potential due to residual epigenetic memory and protocol compatibility. We highlight the need for refined protocols and rigorous benchmarking of hPSC-derived models, particularly for regionally specified neuronal subtypes. Our study underscores the complex relationship between epigenetic status, cell lineage, protocol adaptation, and differentiation outcome. Paper SummaryHuman pluripotent stem cells (hPSCs) are widely used to study otherwise inaccessible human cell phenotypes. However, ensuring the molecular authenticity of hPSC-derived cell types remains critical, as differences between hPSC-derived cells and their native counterparts may impact the validity of these models. Here, medium spiny neurons (MSNs; relevant for studying basal ganglia function and disorders such as Huntingtons disease), serve as a valuable prototype for evaluating the fidelity of hPSC-derived cell types. This study generated human induced pluripotent stem cells (hiPSCs) from developing fetal striatal tissues and fibroblasts, differentiating them into MSN-like cells alongside a human embryonic stem cell (hESC) line. Using single-cell RNA sequencing and DNA methylation analysis, we compared these hPSC-derived MSNs to authentic fetal MSNs. Our findings reveal a significant epigenetic gap between hPSC-derived and authentic MSNs, suggesting that hPSC-MSNs do not acquire a complete and normal striatal epigenome. Additionally, while genetic expression of hPSC-MSNs was striatal-like, it was not equivalent, indicating abberant cells and a failure to reproduce an authentic phoenotype. This study provides insights into the challenges of achieving molecular authenticity in hPSC-derived cells and underscores the need for rigorous evaluation to enhance their utility in research and medicine.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Stem Cell Reports
118 papers in training set
Top 0.1%
27.1%
2
PLOS ONE
4510 papers in training set
Top 17%
10.6%
3
Scientific Reports
3102 papers in training set
Top 12%
7.1%
4
Stem Cell Research
16 papers in training set
Top 0.1%
4.5%
5
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 1%
4.5%
50% of probability mass above
6
Neurobiology of Disease
134 papers in training set
Top 1%
4.1%
7
Stem Cell Research & Therapy
30 papers in training set
Top 0.1%
3.8%
8
Biology Methods and Protocols
53 papers in training set
Top 0.4%
2.9%
9
Stem Cells
28 papers in training set
Top 0.1%
2.2%
10
Epigenetics & Chromatin
42 papers in training set
Top 0.1%
1.9%
11
Cells
232 papers in training set
Top 2%
1.8%
12
iScience
1063 papers in training set
Top 13%
1.8%
13
Cell Reports Methods
141 papers in training set
Top 3%
1.6%
14
Open Biology
95 papers in training set
Top 1%
1.2%
15
Frontiers in Genetics
197 papers in training set
Top 8%
0.9%
16
BMC Genomics
328 papers in training set
Top 5%
0.8%
17
Wellcome Open Research
57 papers in training set
Top 2%
0.8%
18
Human Molecular Genetics
130 papers in training set
Top 3%
0.8%
19
Molecular Omics
21 papers in training set
Top 0.4%
0.8%
20
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 1%
0.7%
21
International Journal of Molecular Sciences
453 papers in training set
Top 17%
0.7%
22
Brain Research
35 papers in training set
Top 2%
0.7%
23
Genes
126 papers in training set
Top 4%
0.5%
24
Cytotherapy
14 papers in training set
Top 0.4%
0.5%
25
Molecular Biology Reports
19 papers in training set
Top 0.8%
0.5%
26
Heliyon
146 papers in training set
Top 9%
0.5%